Nisa Investment Advisors
XERS icon

Nisa Investment Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Nisa Investment Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Hold
2,204
– – ﹤0.01% 2151
2025
Q4 		$17.3K Hold
2,204
– – ﹤0.01% 1994
2025
Q3 		$17.9K Hold
2,204
– – ﹤0.01% 2049
2025
Q2 		$10.3K Buy
2,204
+1,485
+207% +$6.8K ﹤0.01% 2249
2025
Q1 		$3.95K Hold
719
– – ﹤0.01% 2305
2024
Q4 		$2.44K Hold
719
– – ﹤0.01% 2432
2024
Q3 		$2.05K Buy
719
+340
+90% +$873 ﹤0.01% 2390
2024
Q2 		$853 Buy
+379
New +$764 ﹤0.01% 2552
2023
Q1 		– Sell
-30
Closed – – 2736
2022
Q4 		$0 Buy
+30
New +$42 ﹤0.01% 2745

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nisa Investment Advisors's XERS Position: Q1 2026 in Review

Nisa Investment Advisors held its Xeris Biopharma Holdings (XERS) position steady in Q1 2026 at 2,204 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2151.

Nisa Investment Advisors first reported a position in XERS in Q4 2022 and has held it in 9 quarters since. The position peaked at $17.9K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Nisa Investment Advisors held 2,204 shares of Xeris Biopharma Holdings worth $12.8K as of Q1 2026.
  • Nisa Investment Advisors left its Xeris Biopharma Holdings share count unchanged in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2151 holding.
  • Nisa Investment Advisors first reported a position in Xeris Biopharma Holdings in Q4 2022 and has held it in 9 quarters since.
  • Nisa Investment Advisors's Xeris Biopharma Holdings position peaked at $17.9K in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.